[1] |
DICKSON D W. Neuropathology of Parkinson disease[J]. Parkinsonism Relat Disord, 2018, 46(1): 30-33.
doi: 10.1016/j.parkreldis.2017.10.013
|
[2] |
LI Y X, TAN M D, FAN H, et al. Neurobehavioral effects of LSVT® LOUD on auditory-vocal integration in Parkinson's disease: a preliminary study[J]. Front Neurosci, 2021, 15: 624801.
doi: 10.3389/fnins.2021.624801
|
[3] |
OSAKI Y, MORITA Y, MIYAMOTO Y, et al. Disease progression and phenotypes of non‐motor symptoms in Parkinson's disease[J]. Neurol Clin Neurosci, 2020, 9(1): 83-90.
doi: 10.1111/ncn3.12468
|
[4] |
李咏雪, 谭茗丹, 范豪, 等. 励-协夫曼言语治疗对中国帕金森病患者言语功能的影响[J]. 中华物理医学与康复杂志, 2020, 42(3): 245-248.
|
|
LI Y X, TAN M D, FAN H, et al. Lee Silverman voice therapy can improve the speech of Chinese-speakers with Parkinson's disease[J]. Chin J Phys Med Rehabil, 2020, 42(3): 245-248.
|
[5] |
SCHALLING E, JOHANSSON K, HARTELIUS L. Speech and communication changes reported by people with Parkinson's disease[J]. Folia Phoniatr Logop, 2017, 69(3): 131-141.
doi: 10.1159/000479927
|
[6] |
SAPIR S. Multiple factors are involved in the dysarthria associated with Parkinson's disease: a review with implications for clinical practice and research[J]. J Speech Lang Hear Res, 2014, 57: 1330-1343.
doi: 10.1044/2014_JSLHR-S-13-0039
|
[7] |
BRABENEC L, MEKYSKA J, GALAZ Z, et al. Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation[J]. J Neural Transm (Vienna), 2017, 124(3): 303-334.
|
[8] |
MISHRA A, SINGH S, SHUKLA S. Physiological and functional basis of dopamine receptors and their role in neurogenesis: possible implication for Parkinson's disease[J]. J Exp Neurosci, 2018, 31(12):1-8.
|
[9] |
GRIFFITHS S, BARNES R, BRITTEN N, et al. Investigating interactional competencies in Parkinson's disease: the potential benefits of a conversation analytic approach[J]. Int J Lang Commun Disord, 2011, 46(5): 497-509.
doi: 10.1111/j.1460-6984.2011.00012.x
|
[10] |
WALSHE M, PEACH R K, MILLER N. Dysarthria impact profile: development of a scale to measure psychosocial effects[J]. Int J Lang Commun Disord, 2009, 44(5): 693-715.
doi: 10.1080/13682820802317536
|
[11] |
LETANNEUX A, WALSHE M, VIALLET F, et al. The dysarthria impact profile: a preliminary French experience with Parkinson's disease[J]. Park Dis, 2013, 2013: 403680.
|
[12] |
CARDOSO R, GUIMARAES I, SANTOS H, et al. Psychosocial impact of Parkinson's disease-associated dysarthria: cross-cultural adaptation and validation of the dysarthria impact profile into European Portuguese[J]. Geriatr Gerontol Int, 2018, 18(5): 767-774.
doi: 10.1111/ggi.13255
|
[13] |
BEATON D E, BOMBARDIER C, GUILLEMIN F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures[J]. Spine (Phila Pa 1976), 2000, 25: 3186-3191.
doi: 10.1097/00007632-200012150-00014
|
[14] |
POSTUMA R B, BERG D, STERN M, et al. MDS clinical diagnostic criteria for Parkinson's disease[J]. Mov Disord, 2016, 30(12): 1591-1601.
doi: 10.1002/mds.26424
|
[15] |
HOEHN M M, YAHR M D. Parkinsonism: onset, progression, and mortality[J]. Neurology, 1967, 17: 427-442.
doi: 10.1212/WNL.17.5.427
|
[16] |
GUERREIRO M, SILVA A P, BOTELHO M A, et al. Adaptação à população portuguesa da tradução do Mini Mental State Examination (MMSE)[J]. Rev Port Neurol, 1994, 1: 9-10.
|
[17] |
JACOBSON B H, JOHNSON A, GRYWALSKI C, et al. The Voice Handicap Index (VHI): development and validation[J]. Am J Speech Lang Pathol, 1997, 6(3): 66-70.
|
[18] |
MCHORNEY C A, WARE J E, RACZEK A E. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs[J]. Med Care, 1993, 31: 247-263.
doi: 10.1097/00005650-199303000-00006
|
[19] |
MUKAKA M M. A guide to appropriate use of correlation coefficient in medical research[J]. Malawi Med J, 2012, 24:69-71.
|
[20] |
TERWEE C B, BOT S D M, DE BOER M R, et al. Quality criteria were proposed for measurement properties of health status questionnaires[J]. J Clin Epidemiol, 2007, 60: 34-42.
doi: 10.1016/j.jclinepi.2006.03.012
|
[21] |
World Health Organization. International Classification of Functioning, Disability and Health: ICF[R]. Geneva: World Health Organization, 2001.
|
[22] |
FRANIC D M, BRAMLETT R E, BOTHE A C. Psychometric evaluation of disease specific quality of life instruments in voice disorders[J]. J Voice, 2005, 19: 300-315.
doi: 10.1016/j.jvoice.2004.03.003
|